Clinical trial
Cue Reactivity Modulation in MSM With Methamphetamine Use Disorder
NCT07086014 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cue Reactivity Modulation in MSM With Methamphetamine Use Disorder
- Lead sponsor
- Icahn School of Medicine at Mount Sinai
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 19, 2024
- Completion date
- August 30, 2025
- Enrollment
- 88 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
methamphetamine use disorder